Difference between revisions of "Matsuyama S, et al, J Virol (2010), cited as Ref 24 in DOI:10.1007/s11886-020-01292-3 (Q10533)"
Jump to navigation
Jump to search
(Created claim: Fourth Author string (P152): Kawase M, #quickstatements; #temporary_batch_1592503336917) |
(Created claim: Fifth Author string (P153): Takeda M, #quickstatements; #temporary_batch_1592503455634) |
||
| Property / Fifth Author string | |||
| + | Takeda M | ||
| Property / Fifth Author string: Takeda M / rank | |||
| + | Normal rank | ||
Revision as of 18:04, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Matsuyama S, et al, J Virol (2010), cited as Ref 24 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2 (English)
0 references
Matsuyama S
0 references
Nagata N
0 references
Shirato K
0 references
Kawase M
0 references
Takeda M
0 references
